The federal response to the opioid crisis : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, first session, on examining the federal response to the opioid crisis, October 5, 2017.
Series United States. S. hrg ; 115-636.Editor: Washington : U.S. Government Publishing Office, 2019Descripción: 1 online resource (iv, 99 pages)Tipo de contenido:- United States. Comprehensive Addiction and Recovery Act of 2016
- United States. 21st Century Cures Act
- United States. Substance Abuse and Mental Health Services Administration -- Rules and practice
- Center for Disease Control -- Rules and practice
- National Institutes of Health (U.S.) -- Rules and practice
- Opioid abuse -- Government policy -- United States -- Prevention
- Opioids -- Overdose -- Government policy -- United States -- Prevention
- Pain -- Alternative treatment -- United States
- KF26 .L27 2017q
| Imagen de cubierta | Tipo de ítem | Biblioteca actual | Biblioteca de origen | Colección | Ubicación en estantería | Signatura topográfica | Materiales especificados | Info Vol | URL | Copia número | Estado | Notas | Fecha de vencimiento | Código de barras | Reserva de ítems | Prioridad de la cola de reserva de ejemplar | Reservas para cursos | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Recurso en Internet | Biblioteca de Derecho Mons. Fremiot Torres Oliver Online | Y 4.L 11/4:S.HRG.115-636 (Navegar estantería(Abre debajo)) | 1 | Disponible | Y 4.L 11/4:===ONLINE |
Access ID (govinfo): CHRG-115shrg27121.
CRDP Program record.
Includes bibliographical references.
Hearing witnesses: Statement of Elinore F. McCance-Katz, M.D., Ph.D., Assistant Secretary for Mental Health and Substance Use, Substance Abuse and Mental Health Services Administration, Rockville, MD; Statement of Debra Houry, M.D., MPH, Director, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA; Statement of Francis Collins, M.D., Ph.D., Director, National Institutes of Health, Bethesda, MD; Statement of Scott Gottlieb, M.D., Commissioner, Food and Drug Administration, Silver Spring, MD.
Date of hearing: 2017-10-05.
Description based on online resource; title from PDF title page (govinfo, viewed Aug. 02, 2019).